Hospital Universitario Dr. We reviewed the available evidence on ischaemic stroke and TIA prevention according to aetiological subtype. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: design and rationale for the. Francisco Bosa. A. Slotwiner. , M. , Alexander Slotwiner. García del Blanco, MD. , Atul Sharma, M. PRO